Pureland Global Venture

Active

Overview

Pureland Global Venture is a direct investment fund and part of the Pureland Group that targets impact investments in the medical technology sector. The firm focuses on early-stage companies in seed to Series A stages that aim to enhance patient care and address healthcare gaps, particularly in underserved markets across the Asia-Pacific region, India, and the United States. The fund operates with a dual structure: Fund I focuses on capital preservation in secondary markets, while Fund II is dedicated to impact-driven venture capital investments in medtech.

History

Pureland Group was founded in 2014 as a Singapore-based private investment group. Pureland Global Venture operates as the medical technology investment arm within the broader Pureland Group structure. The firm has received institutional endorsement as a co-investment partner from Enterprise Singapore, enhancing its credibility within the Singapore startup ecosystem. The company was formally registered in Singapore in April 2019 under the legal entity PURELAND GLOBAL VENTURE PTE. LTD.

Product Lines

Product Line	Positioning	Price Range
Fund I - Secondary Markets	Capital preservation through secondary market investments	Not publicly disclosed
Fund II - Impact Venture Capital	Early-stage medtech venture investments with impact focus	Not publicly disclosed

Manufacturing

As a venture capital and investment fund, Pureland Global Venture does not manufacture physical products. The firm provides capital and strategic support to portfolio companies in the medical technology sector, including medical devices and machine learning-based healthcare solutions. Portfolio companies handle their own manufacturing and operations.

Notable Products

Fund I Portfolio - Secondary market investments focused on capital preservation and established medical technology assets
Fund II Portfolio - Early-stage medtech investments targeting companies developing medical devices and ML-based healthcare solutions
Impact Investment Strategy - Structured approach to identifying and funding medical technology companies that improve patient care and reduce healthcare supply-demand gaps

Reputation

Pureland Global Venture is recognized as a credible player in the medical technology investment space, particularly within the Asia-Pacific region. The firm's institutional backing from Enterprise Singapore and its focus on impact-driven investments in underserved healthcare markets distinguish it from traditional venture capital firms. The dual fund structure demonstrates a balanced approach to both capital preservation and growth-oriented investments. Limited public information exists regarding criticisms or challenges faced by the firm.

Sources (8)